The Future of MIGS is here!

The iStent inject, the latest MIGS device from Glaukos, has been approved for mild to moderate open-angle glaucoma in patients undergoing cataract surgery. Are you ready for it?

World-renowned ophthalmologist Thomas W. Samuelson, MD shares his surgical techniques and clinical results in this informative 60-minute webinar. Sightpath Medical is pleased to begin offering the iStent inject to your patients.


This webinar covers:

  • Surgical techniques and clinical results
  • Surgeon training
  • Reimbursement structure
  • How current Sightpath customers may access this technology

Complete the form at the right to view the webinar from Sightpath University.